Logo image of SREV

SERVICESOURCE INTERNATIONAL (SREV) Stock Fundamental Analysis

NASDAQ:SREV - Nasdaq - US81763U1007 - Common Stock - Currency: USD

1.5  +0.01 (+0.67%)

Fundamental Rating

3

Overall SREV gets a fundamental rating of 3 out of 10. We evaluated SREV against 82 industry peers in the IT Services industry. SREV scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SREV is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

SREV had positive earnings in the past year.
SREV Yearly Net Income VS EBIT VS OCF VS FCFSREV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 -20M -40M

1.2 Ratios

Industry RankSector Rank
ROA -8.28%
ROE N/A
ROIC -7.14%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SREV Yearly ROA, ROE, ROICSREV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 -5 -10 -15 -20 -25

1.3 Margins

Industry RankSector Rank
OM -4.36%
PM (TTM) -5.14%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SREV Yearly Profit, Operating, Gross MarginsSREV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 10 -10 20 30

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SREV is destroying value.
The number of shares outstanding for SREV has been increased compared to 1 year ago.
SREV has a better debt/assets ratio than last year.
SREV Yearly Shares OutstandingSREV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M
SREV Yearly Total Debt VS Total AssetsSREV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -0.38, we must say that SREV is in the distress zone and has some risk of bankruptcy.
There is no outstanding debt for SREV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.38
ROIC/WACC-0.72
WACC9.87%
SREV Yearly LT Debt VS Equity VS FCFSREV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50M 100M

2.3 Liquidity

SREV has a Current Ratio of 2.02. This indicates that SREV is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 2.02 indicates that SREV has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 2.02
SREV Yearly Current Assets VS Current LiabilitesSREV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 53.02% over the past year.
The earnings per share for SREV have been decreasing by -14.97% on average. This is quite bad
Looking at the last year, SREV shows a small growth in Revenue. The Revenue has grown by 5.31% in the last year.
SREV shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.00% yearly.
EPS 1Y (TTM)53.02%
EPS 3Y-12.64%
EPS 5Y-14.97%
EPS Q2Q%150%
Revenue 1Y (TTM)5.31%
Revenue growth 3Y-6.35%
Revenue growth 5Y-5%
Sales Q2Q%8.6%

3.2 Future

SREV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.24% yearly.
The Revenue is expected to decrease by -2.09% on average over the next years.
EPS Next Y61.9%
EPS Next 2Y27.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.97%
Revenue Next 2Y-2.09%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SREV Yearly Revenue VS EstimatesSREV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M
SREV Yearly EPS VS EstimatesSREV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -0.1 -0.2 -0.3

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 30.00 indicates a quite expensive valuation of SREV.
SREV is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 29.62, which is the current average of the S&P500 Index.
SREV is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 30
Fwd PE N/A
SREV Price Earnings VS Forward Price EarningsSREV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.84
SREV Per share dataSREV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

SREV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SREV's earnings are expected to grow with 27.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.48
PEG (5Y)N/A
EPS Next 2Y27.24%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SREV!.
Industry RankSector Rank
Dividend Yield N/A

SERVICESOURCE INTERNATIONAL

NASDAQ:SREV (7/20/2022, 8:16:01 PM)

1.5

+0.01 (+0.67%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)05-10 2022-05-10/bmo
Earnings (Next)08-05 2022-08-05/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners6.84%
Ins Owner Change0%
Market Cap150.39M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 30
Fwd PE N/A
P/S 0.75
P/FCF N/A
P/OCF N/A
P/B 2.32
P/tB N/A
EV/EBITDA 20.84
EPS(TTM)0.05
EY3.33%
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.99
BVpS0.65
TBVpSN/A
PEG (NY)0.48
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.28%
ROE N/A
ROCE N/A
ROIC -7.14%
ROICexc N/A
ROICexgc -7.64%
OM -4.36%
PM (TTM) -5.14%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover1.61
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.02
Quick Ratio 2.02
Altman-Z -0.38
F-Score7
WACC9.87%
ROIC/WACC-0.72
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.02%
EPS 3Y-12.64%
EPS 5Y-14.97%
EPS Q2Q%150%
EPS Next Y61.9%
EPS Next 2Y27.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.31%
Revenue growth 3Y-6.35%
Revenue growth 5Y-5%
Sales Q2Q%8.6%
Revenue Next Year-0.97%
Revenue Next 2Y-2.09%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A